2021 journal article

Percutaneous liquid ablation agent for tumor treatment and drug delivery

Science Translational Medicine, 13(580).

co-author countries: United States of America 🇺🇸
MeSH headings : Animals; Carcinoma, Hepatocellular / drug therapy; Humans; Liver Neoplasms / drug therapy; Liver Transplantation; Pharmaceutical Preparations; Rabbits; Treatment Outcome
Source: ORCID
Added: August 10, 2022

An ionic liquid formulation ablates tumors, uniformly distributes drugs in the ablation zone, and has synergistic effects with chemotherapy.